Citi Pharma Limited ne ek ahm joint venture agreement sign kar liya hai All Care Group of Investment ke saath, taake Saudi Arabia mein aik advanced API (Active Pharmaceutical Ingredient) aur Formulation Facility qaim ki ja sake. Yeh ta’awun pharmaceutical industry ke liye ek ahm qadam hai jo Saudi Arabia ke Vision 2030 ke mutabiq hai, jo ke Crown Prince Mohammed Bin Salman Al Saud ki rehnumayi mein khud-kifalati ka hadaf rakhta hai aur Saudi Arabia ko pharmaceutical products ka global exporter banane ka irada rakhta hai.
Is agreement ke tehat, Citi Pharma apni technical expertise ka istimaal karegi aur technology transfer ka nizaam Saudi Arabia mein introduce karegi, jo ke international Good Manufacturing Practices (GMP) ke mutabiq hoga. All Care Group of Investment land acquisition, infrastructure development, product registration Saudi regulatory authorities ke saath, aur local banks se financing ke zimmedar hongay.
Yeh joint venture un APIs aur formulation products ke tehat manufacturing karega jo Saudi Arabia aur broader MENA (Middle East aur North Africa) region ke healthcare needs ko pura kar sakein. Yeh facility ek strategic export hub ke tor par bhi kaam karegi, jahan MENA, South Africa aur doosray regions ko pharmaceutical products supply ki jayengi. Saudi Arabia ki cost-effective raw materials ki availability se production efficiency barh jayegi, aur Citi Pharma ko global pharmaceutical landscape mein ek significant player banane ka moka milega. Saath hi, Citi Pharma ke products ko India, China aur doosray international markets mein bhi export karne ka darwaza khul jayega.
Is venture ka aik ahm pehlu yeh hai ke aindah Saudi Arabia mein local production ke tehat key chemicals jaise ke Naphtha cracker chemicals, Phenol, aur Benzene materials bhi banaye jaayenge, jo abhi Citi Pharma import karti hai. Is facility ke sath, yeh chemicals kam cost par banaye jayenge aur duniya bhar mein export honge, jo ke competitive pricing aur market reach ko faida pohchayenge.
CEO Citi Pharma Limited, Mr. Rizwan Ahmad ne iss partnership ke hawale se kaha: “Yeh joint venture hamari journey mein aik ahm milestone hai jo hamein global pharmaceutical leader banane ke qareeb le jayega. Citi Pharma ki technical expertise aur Saudi Arabia ke strategic resources ko mila kar hum affordable aur high-quality APIs aur formulations ka production karne wale hain, jo na sirf local market balke international markets ke liye bhi faidemand honge.”
Yeh ta’awun Citi Pharma ke Vision 2030 aur Vision 2050 ke goals mein bhi madadgar sabit hoga, jo ke Citi Pharma ko global pharmaceutical industry mein ek leading player banane ka aim rakhta hai. Is joint venture ke zariye Citi Pharma Saudi Arabia ke pharmaceutical sector ke development mein apna ahm kirdar ada karne ke sath global footprint ko bhi mazeed barhane ke liye tayar hai.
